Allogene is ceasing enrollment in a Phase I trial of cema-cel for patients with relapsed or refractory chronic lymphocytic ...

NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year and is in treatment, the National ...

ALL patients who received Aucatzyl immunotherapy, made from their own T cells, experienced complete remission within three ...

Allogene Therapeutics has dropped plans to target one of its allogeneic CAR-Ts at leukemia in the face of competition from ...

Across the street from MD Anderson, at Texas Children's Hospital, Fivecoat's then-nearly 1-year-old granddaughter Whitney was ...

The department used its new system for determining whether a condition is service-connected to give affected veterans access ...

Starting tonight, in solidarity with our brother and current NBA official, Scott Wall, each NBA Referee will be using a #31 ...

A benefit event will be held this weekend to raise funds for medical expenses for a four-year-old girl diagnosed with ...

ROME — A Red Cross blood drive will be held on Saturday at Uvanni Motors on Rome-Taberg Road in honor of 17-year-old Camryn ...

Syndax Pharmaceuticals (SNDX) stock dropped ~23% after the company posted Phase 2 trial data for its AML candidate, revumenib ...

In an interview with Targeted Oncology, Michael Mauro, MD, delved into the rapidly advancing field of chronic myeloid ...

NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year and is in treatment, the National ...